There is no shortage of interesting things going on in Washington, D.C., these days, from impeachment inquiries to funding the government to deciding on a Democratic nominee for the 2020 election. On September 28, our clinical leaders came to Washington to use their voice to advocate for a range of issues, including the renewal of...
On September 10, the United States Environmental Protection Agency (EPA) issued a directive to aggressively prioritize reductions in animal testing towards a 30% decrease in such tests by 2025, and complete elimination of requests by the EPA for animal studies by 2035. In a companion memo by EPA Administrator Andrew Wheeler, the EPA also announced...
Limiting access to food in mice increases levels of the hormone, ghrelin, which may also increase motivation to exercise, according to a study published in the Journal of Endocrinology. The study suggests that a surge in levels of appetite-promoting hormone, ghrelin, after a period of fasting prompted mice to initiate voluntary exercise. These novel findings...
As part of the Endocrine Society’s commitment to improving public health by reducing exposure to endocrine-disrupting chemicals (EDCs), our members work with international organizations and participate in many international meetings to provide advice and guidance to regulators and policymakers worldwide. One example is the Organization for Economic Cooperation and Development (OECD), which has worked since...
In early November, the Endocrine Society attended the American Medical Association (AMA) House of Delegates meeting to establish policy positions on topics of importance to patients and healthcare providers. Our delegation is comprised of Society members Amanda Bell, MD, Palak Choksi, MD, Shivani Agarwal, MD, Barbara Onumah, MD, Robert Vigersky, MD, and Daniel Spratt, MD....
On October 1, the Endocrine Society partnered with the Diabetes Patient Advocacy Coalition to advocate for increased access to diabetes self-management training services and to educate Members of Congress about ways to address rising insulin costs. The joint Hill Day marks the first time that Society members have accompanied patients, caregivers, and diabetes educators to...
The Endocrine Society awarded co-chairs of the Congressional and Senate Diabetes Caucuses with the Diabetes Champion Award for their outstanding work in promoting research and prevention efforts for people with diabetes. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) and Representatives Tom Reed (R-NY) and Diana DeGette (D-CO 1st District) received the award for their work reauthorizing the Special Diabetes Program (SDP) at...
This week’s Washington headlines were dominated by the continuation of the Supreme Court confirmation hearing of Judge Brett Kavanaugh. However, we also saw important congressional action supporting Endocrine Society legislative priorities: Appropriations – The House of Representatives passed the combined Labor-HHS/Defense spending package. The same bill passed the Senate last week. The bill, which includes...
There is no shortage of interesting things going on in Washington, D.C., these days, from impeachment inquiries to funding the government to deciding on a Democratic nominee for the 2020 election. On September 28, our clinical leaders came to Washington to use their voice to advocate for a range of issues, including the renewal of...
On October 1, the Endocrine Society partnered with the Diabetes Patient Advocacy Coalition to advocate for increased access to diabetes self-management training services and to educate Members of Congress about ways to address rising insulin costs. The joint Hill Day marks the first time that Society members have accompanied patients, caregivers, and diabetes educators to...
